OptimizeRx Corporation Q2 2026 Earnings Recap

Shares surged 26.9% following Q2 results that beat revenue and adjusted EBITDA expectations, driven by ongoing margin expansion and strong commercial momentum in AI-enabled offerings and platform innovation.

Key Takeaways

• Q2 revenue reached $20.5 million with adjusted EBITDA of $4.9 million, both surpassing consensus estimates.
• Despite some revenue declines from a few large customers transitioning away from lower-margin services, growth was evident across the broader business.
• AI-enabled software subscriptions grew 25% year-over-year, underscoring a successful shift toward recurring revenue models.
• Three new product launches, including integration with DeepIntent’s DSP and the AI-powered natural language audience builder, bolster the company’s competitive position.
• Reiteration of full-year 2026 guidance ($95–100 million revenue; $21–25 million adjusted EBITDA) reflects confidence despite some near-term revenue variability.